Prerequisites for a dry powder inhaler for children with cystic fibrosis.
Correct inhalation technique is essential for effective use of dry powder inhalers (DPIs), as their effectiveness largely depends on the patient's inhalation manoeuvre. Children are an especially challenging target population for DPI development due to the large variability in understanding and...
Saved in:
| Main Authors: | Anne J Lexmond, Paul Hagedoorn, Henderik W Frijlink, Bart L Rottier, Anne H de Boer |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0183130&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Experience of the use of tobramycin for inhalation in children with cystic fibrosis
by: A. V. Orlov, et al.
Published: (2012-02-01) -
Comprehensive In Vitro and In Silico Aerodynamic Analysis of High-Dose Ibuprofen- and Mannitol-Containing Dry Powder Inhalers for the Treatment of Cystic Fibrosis
by: Petra Party, et al.
Published: (2024-11-01) -
INNOVATION APPROACHES TO THE DEVELOPMENT OF DRY POWDER INHALERS
by: A. N. Vorobyev, et al.
Published: (2019-01-01) -
Dry Powder Inhalers for Delivery of Synthetic Biomolecules
by: Hossein Omidian, et al.
Published: (2025-01-01) -
Pulmonary delivery of insulin by dry powder inhaler formulations
by: Mohsen Imenshahidi, et al.
Published: (2025-07-01)